Inactive Total Small Business Set-Aside (FAR 19.5)

Questions & Answers Updated (see attachment) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in subpart 12.6, as supplemented with additional infor... Questions & Answers Updated (see attachment) This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in subpart 12.6, as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. (ii) The solicitation number and a statement that the solicitation is issued as a request for quotation (RFQ). (iii) A statement that the solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular FAR FAC 2021-06 July 12. (iv) This is a total 100% small business set-aside and the associated NAICS code is 541715 and small business size standard is 1000 employees. (v) See attached document (Statement of Work). (vi) USDA, Agricultural Research Service (ARS), Plum Island Animal Disease Center (PIADC) in Orient Point, NY, requires custom modifications to their in house Plum Island Porcine Epithieal Cells (PIPEC) cell line, including deletions of specific genes, and insertions of different reporters. *Please see Statement of Work for details* (vii) Performance location: USDA, ARS, NEA, PIADC, 40550 Route 25, Bldg. 101 Mod 1, Orient, NY 111957. (viii) Provision at 52.212-1, Instructions to Offerors-Commercial, applies to this acquisition. (ix) Provision at 52.212-2, Evaluation-Commercial Items, applies to this acquisition. The Government intends to award a Firm Fixed-Price (FFP) contract. The award will be made on the basis of Lowest Price Technically Acceptable (LPTA). "LPTA" means, the expected outcome of the acquisition, that results from the selection of the lowest evaluated price (evaluated as total cost of all line items) is a technically acceptable quotation, that fully meets all specifications listed. *Vendor must provide proof of capabilities to produce modifications to cell lines that increased vaccine production. Pricing and past performance will also be included in the selection process*. Only the lowest priced quote will be evaluated for technical acceptability (based on the specifications). The next lowest offer will only be evaluated if the aforementioned quote is not found technically acceptable (and so on). Only one award will be made under this solicitation based on availability of funding. (x) Offers must have a completed copy of the provision at 52.212-3, Offeror Representations and Certifications-Commercial Items, uploaded on beta.sam.gov by the time quotes are due. (xi) The clause at 52.212-4, Contract Terms and Conditions-Commercial Items, applies to this acquisition. (xii) The clause at 52.212-5, Contract Terms and Conditions Required To Implement Statutes or Executive Orders-Commercial Items, applies to this acquisition. See attached clauses for additional applicable clauses. (xiv) Questions are due by 13 August 2021. Quotes are due on 17 August 2021 at noon EST by email to Dilynn Rogers at dilynn.rogers@usda.gov.